British pharmaceutical giant GlaxoSmithKline said Monday that the European Union has allowed it to market Cervarix -- a drug used to treat cervical cancer.
"The decision (by the European Commission) to approve Cervarix for the European Union represents a great step forward for European women," GSK chief executive JP Garnier said in a statement.
Cervical Cancer - Incidence
Cervical cancer is the second most common cancer among women and is the primary cause of cancer-related deaths in developing countries
Advertisement
"Physicians across Europe will now have access to this important vaccine to help protect women against cervical cancer, the second most common cancer in women," he added.
The EU consists of 27 nations, including Britain, France and Germany.
Source: AFP
SRM /J
Source: AFP
SRM /J
Vinegar for Cervical Cancer Surveillance
Visual Inspection With Acetic acid (VIA) is a cheap and effective method detect cervical cancer in rural women.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Drug News
The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.
Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.
Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.
In June, WHO raised concerns about 7 Indian cough syrups after complaints from several countries about contamination and health issues.
Women using hormonal contraception, along with their healthcare providers, should explore alternative pain relief options instead of NSAIDs.
